Understanding how metformin helps with fatty liver disease
Investigating the involvement of small intestine in metformin's effect on hepatic lipid metabolism
This research explores how the common diabetes medication metformin works in the small intestine to improve fatty liver disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | North Carolina State University Raleigh NIH-funded |
| Lab location | 1 site (Raleigh, United States) |
| Project ID | NIH-11116898 on NIH RePORTER |
What this research studies
Nonalcoholic fatty liver disease (NAFLD) is very common, but there are no approved medications to treat it. Metformin is often discussed as a potential treatment, but we need to better understand how it works. This project aims to discover how metformin affects fat metabolism in the liver and how the small intestine plays a role in these effects. By using advanced techniques, we hope to get a clearer picture of metformin's actions in different organs.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients but focuses on understanding a condition that affects individuals with nonalcoholic fatty liver disease.
Not a fit: Patients without nonalcoholic fatty liver disease would not directly benefit from the findings of this specific research.
Why it matters
Potential benefit: If successful, this research could lead to a better understanding of metformin's role in treating fatty liver disease and potentially guide the development of new, more effective treatments.
How similar studies have performed: While metformin is widely used, its specific effectiveness and mechanisms for treating NAFLD are still being actively investigated, with previous reports showing inconsistent results.
Where this research is happening
Raleigh, United States
- North Carolina State University Raleigh — Raleigh, United States (Active)
Researchers
- Principal investigator: Liu, Xiaojing — North Carolina State University Raleigh
- Study coordinator: Liu, Xiaojing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.